Sibutramine Hydrochloride for obesity and weight loss.pdf

4. What is sibutramine?
Discovered in 1988 by Boots and later developed and marketed by BASF/Knoll AG and Abbott Laboratories, Sibutramine was initially approved for treating obesity in 1997. Sibutramine has been sold under the following brand names; Sibutrex, Siredia, Meridia, Reductil among others. Sibutramine belongs to the drug class known as appetite suppressants or anorexiants. More specifically, it is classified as a serotonin-norepinephrine-dopamine reuptake inhibitor (SNDRI). This class of drugs works by affecting neurotransmitters in the brain to reduce appetite and promote a feeling of satiety, helping in weight loss and the management of obesity. However, due to significant cardiovascular risks, sibutramine has been withdrawn from the market in many countries.

Although banned in many countries, sibutramine is sometimes found in illegal weight loss supplements sold online or through informal markets.

5. Sibutramine hydrochloride Mechanism of Action
The effectiveness of sibutramine hydrochloride as a weight loss aid lies in its unique mechanism of action. As a serotonin-norepinephrine reuptake inhibitor (SNRI), sibutramine increases the levels of serotonin, norepinephrine, and to a lesser extent, dopamine in the synaptic cleft by inhibiting their reuptake into the presynaptic neuron. This inhibition enhances the feeling of satiety and reduces appetite, leading to decreased food intake and, consequently, weight loss.

The drug's primary targets are the serotonin (5-HT) and norepinephrine (NE) transporters. By blocking these transporters, sibutramine prevents the reabsorption of these neurotransmitters, thereby prolonging their action. This increased neurotransmitter activity helps modulate brain circuits involved in hunger and energy expenditure.

Additionally, sibutramine hydrochloride has been found to promote thermogenesis, the process by which the body generates heat and energy expenditure, which further contributes to weight loss. This dual-action mechanism—appetite suppression and increased energy expenditure—makes sibutramine hydrochloride a powerful tool in the fight against obesity.

1. www.aea.ltd
APICMO&CDMOManufacturer
Email:[email protected]
SibutramineHydrochlorideforobesityandweightloss
Repostfrom:https://www.aea.ltd/sibutramine-hydrochloride-for-obesity-and-weight-loss/

2. www.aea.ltd
APICMO&CDMOManufacturer
Email:[email protected]
1.Factsaboutobesity
OverweightandobesitytogethermakeuponeoftheleadingpreventablecausesofdeathintheU.S.Obesityisachronic
diseasethatcanseriouslyaffectyourhealth.
Overweightmeansthatyouhaveextrabodyweight,andobesitymeanshavingahighamountofextrabodyfat.Being
overweightorobeseraisesyourriskforhealthproblems.Theseincludecoronaryheartdisease,type2diabetes,asthma,
highcholesterol,osteoarthritis,highbloodpressure,sleepapnea,andcertaintypesofcancer.
Publichealthexpertsagreethatoverweightandobesityhavereachedepidemicproportionsinthiscountryandaround
theworld.MorethanathirdofU.S.adultsareobese.Peopleages60andolderaremorelikelytobeobesethanyounger
adults,accordingtothemostrecentdatafromtheNationalHealthandNutritionExaminationSurvey.Andtheproblem
alsoaffectschildren.Approximately20%,ofU.S.childrenandadolescentsages2to19areobese.

3. www.aea.ltd
APICMO&CDMOManufacturer
Email:[email protected]
2.WhatisObesity?
Obesityisamedicalconditioncharacterizedbyanexcessiveaccumulationofbodyfatthatposesarisktohealth.Aperson
issaidtobeobeseiftheyhavesuchahighexcessofbodyfatthattheirhealthmightbeaffected.Thisconditionis
commonlymeasuredusingtheBodyMassIndex(BMI),whichisaperson'sweightinkilogramsdividedbythesquareof
theirheightinmeters.HealthworkersuseBMItoassessobesity,asitusuallyprovidesagoodestimateofbodyfat.
Variousfactorscontributetoobesity,includinggeneticpredisposition,poordietaryhabits,lackofphysicalactivity,and
certainmedicalconditions.
TocalculateBMI,youusetheformula:
BMI=mass(kg)÷height²(m²)
Forexample,ifapersonhasamassof60kgandaheightof1.65m:
BMI=60kg÷1.65²

4. www.aea.ltd
APICMO&CDMOManufacturer
Email:[email protected]
BMI=22kg/m²
ABMIbetween25and30kg/m²isconsideredoverweight,whileaBMIover30kg/m²isclassifiedasobese.Intheexample
above,theindividualwithaBMIof22kg/m²fallswithinthehealthyweightrange.Obesityisnotmerelyamatterof
appearancebutaserioushealthconcernwithwide-rangingimplications.

5. www.aea.ltd
APICMO&CDMOManufacturer
Email:[email protected]
3.WhyYouNeedtoLoseWeight
Losingweightiscrucialforimprovingoverallhealthandqualityoflife.Reducingexcessbodyfatcanlowertheriskof
serioushealthconditionssuchasheartdisease,diabetes,andcertaincancers,leadingtoalongerandhealthierlife.
Weightlosstranslatesintoimprovedmetabolism,whichbeginstooccurwhenpeoplewithobesitylosearound10%of
theircurrentweight.
Furthermore,losingweightreducestheriskofmyocardialinfarction(heartattack)andheartdisease.Italsodecreasesthe
likelihoodofdevelopinghighbloodpressureandsleepapnea,andithelpstolowerbadcholesterol(LDL)andtriglycerides
whileincreasinggoodcholesterol(HDL).Thesechangescollectivelycontributetobettercardiovascularhealthandoverall
well-being.
Youmayhaveattemptedtoloseweightandkeepitoffmanytimesinthepast.Theupsanddownscancertainlybe
difficult,butyoumayfinallybeabletoloseweightandkeepitoffwiththehelpofSibutraminehydrochloride.

6. www.aea.ltd
APICMO&CDMOManufacturer
Email:[email protected]
4.Whatissibutramine?
Discoveredin1988byBootsandlaterdevelopedandmarketedbyBASF/KnollAGandAbbottLaboratories,Sibutramine
wasinitiallyapprovedfortreatingobesityin1997.Sibutraminehasbeensoldunderthefollowingbrandnames;Sibutrex,
Siredia,Meridia,Reductilamongothers.Sibutraminebelongstothedrugclassknownasappetitesuppressantsor
anorexiants.Morespecifically,itisclassifiedasaserotonin-norepinephrine-dopaminereuptakeinhibitor(SNDRI).This
classofdrugsworksbyaffectingneurotransmittersinthebraintoreduceappetiteandpromoteafeelingofsatiety,
helpinginweightlossandthemanagementofobesity.However,duetosignificantcardiovascularrisks,sibutraminehas
beenwithdrawnfromthemarketinmanycountries.
Althoughbannedinmanycountries,sibutramineissometimesfoundinillegalweightlosssupplementssoldonlineor
throughinformalmarkets.

7. www.aea.ltd
APICMO&CDMOManufacturer
Email:[email protected]
5.SibutraminehydrochlorideMechanismofAction
Theeffectivenessofsibutraminehydrochlorideasaweightlossaidliesinitsuniquemechanismofaction.Asa
serotonin-norepinephrinereuptakeinhibitor(SNRI),sibutramineincreasesthelevelsofserotonin,norepinephrine,andto
alesserextent,dopamineinthesynapticcleftbyinhibitingtheirreuptakeintothepresynapticneuron.Thisinhibition
enhancesthefeelingofsatietyandreducesappetite,leadingtodecreasedfoodintakeand,consequently,weightloss.
Thedrug'sprimarytargetsaretheserotonin(5-HT)andnorepinephrine(NE)transporters.Byblockingthesetransporters,
sibutraminepreventsthereabsorptionoftheseneurotransmitters,therebyprolongingtheiraction.Thisincreased
neurotransmitteractivityhelpsmodulatebraincircuitsinvolvedinhungerandenergyexpenditure.
Additionally,sibutraminehydrochloridehasbeenfoundtopromotethermogenesis,theprocessbywhichthebody
generatesheatandenergyexpenditure,whichfurthercontributestoweightloss.Thisdual-actionmechanism—appetite

8. www.aea.ltd
APICMO&CDMOManufacturer
Email:[email protected]
suppressionandincreasedenergyexpenditure—makessibutraminehydrochlorideapowerfultoolinthefightagainst
obesity.

9. www.aea.ltd
APICMO&CDMOManufacturer
Email:[email protected]
6.UnderstandSibutraminehydrochloridepowder
(1)WhatisSibutramineHydrochloridePowder?
Therewastwomainrawpowderrelatetosibutramine,theyaresibutraminepowderandSibutraminehydrochloride
powder.Theyaretheactiveingredientinsibutramine-basedmedications.Theyareacrystallinepowderthatistypically
whiteoroff-whiteincolorandisusedtoformulateoralweightlossmedications.
(2)SibutraminepowderChemicalstructure

10. www.aea.ltd
APICMO&CDMOManufacturer
Email:[email protected]
(3)Sibutraminehydrochloridepowderstructure

11. www.aea.ltd
APICMO&CDMOManufacturer
Email:[email protected]
Sibutraminehydrochloride,orsibutraminehclisthehydrochloridesaltformofsibutramine.Sibutramineandsibutramine
hydrochloridediffermainlyinthepresenceofachlorideioninthelatter,whichispartofitssaltform.Bothcompounds

12. www.aea.ltd
APICMO&CDMOManufacturer
Email:[email protected]
shareacommonchemicalbackboneandexertsimilarpharmacologicaleffectsasappetitesuppressantsand
antidepressants,thoughsibutraminehasbeenlargelywithdrawnfromthemarketduetosafetyconcerns.
Sibutraminehydrochlrodiehasabetterstabilityandsolubilitythansibutramine,soitispreferredbymanufacturerand
supplementcompany.Aea.ltdasweightlosspowdermanufacturer,wesupplySibutraminehydrochloridepowder
wholesale.
7.Sibutraminehyrdrochlorideuses
Whensibutraminewasavailableforsaleinthemarket,itwasprescribedtoaidweightlossinobesepatientswithabody
massindex(BMI)of30kg/m²orgreater,orthosewithaBMIof27kg/m²orgreaterwhohadadditionalriskfactorssuch
astype2diabetesordyslipidemia.
①TreatmentofObesity

13. www.aea.ltd
APICMO&CDMOManufacturer
Email:[email protected]
TheprimaryuseofSibutraminehydrochlorideisinthetreatmentofobesity.Byinhibitingthereuptakeofnorepinephrine,
serotonin,anddopamine,Sibutramineenhancesfeelingsofsatietyandreducesoverallfoodintake.Thismechanismhelps
individualsachievesignificantweightlosswhencombinedwithareduced-caloriedietandincreasedphysicalactivity.
②WeightMaintenance
Sibutramineisalsousedforlong-termweightmaintenance.Afteraninitialperiodofweightloss,maintainingareduced
bodyweightcanbechallenging.Sibutramineaidsinpreventingweightregainbysustainingneurotransmitterlevelsthat
promotesatiety,thushelpingindividualsmaintaintheirweightlossovertime.
③ImprovementofMetabolicParameters
Inadditiontoitsweightlossbenefits,Sibutraminehydrochloridecontributestotheimprovementofvariousmetabolic
parameters.Ithasbeenshowntopositivelyaffectbloodlipidprofiles,reducingLDLcholesterolandincreasingHDL
cholesterol.Thesechangeshelplowertheriskofcardiovasculardiseasesandimproveoverallmetabolichealth.

14. www.aea.ltd
APICMO&CDMOManufacturer
Email:[email protected]
8.ApplicationsofSibutramineHydrochloridePowder
BeforeSibutraminedrawbackfromthemarket,therearemultipleapplicationofSibutramineHydrochloridepowder.
Manufacturerwillmaketherawpowderintoweightlosscapsules,pills.Somesupplierswillusesibutraminehydrochloride
powdertomakeweightlosssupplementssuchasweightlosstea,sibutraminecoffee,sibutraminechocolate..etc.Weight
losssupplementsprovideafamiliarandenjoyablemethodforappetitesuppressionandenergyenhancement.
①WeightLossCapsules
Sibutraminehydrochloridepowderiscommonlyformulatedintoweightlosscapsules.Thesecapsulestypicallycomein
dosagesof5mg,10mg,and15mg.Thepowderiscombinedwithotheringredientssuchasstarch,glucose,andlactoseto
createaneffectiveandeasy-to-useproduct.Themanufacturingprocessinvolvesusingairpressurefillingequipmentto
ensureprecisedosingandmechanicalmixingequipmenttoensurethoroughblendingofsibutraminewithother

15. www.aea.ltd
APICMO&CDMOManufacturer
Email:[email protected]
components.Thesecapsulesareaconvenientmethodforindividualsseekingtomanagetheirweightthroughcontrolled
appetitesuppressionandincreasedsatiety.
②SibutramineCoffee
Sibutraminehydrochloridepowderisalsousedtocreateslimmingcoffee,apopularweightlossproduct.Thisinnovative
applicationinvolvesmixingsibutraminewithinstantcoffeeandotheringredients.Theresultingdrinkisconsumedlike
regularcoffeebutincludestheaddedbenefitofweightlosssupport.Userstypicallyconsumethecoffeefifteenminutes
beforebreakfasttomaximizeitsappetite-suppressingeffects.Slimmingcoffeeisparticularlyappealingtovegetariansand
vegans,asitcaneasilybeintegratedintotheirdietaryregimen.Thismethodnotonlyhelpscontrolfoodintakebutalso
boostsenergylevels,makingitafavoredoptionforthoseaimingtoloseweightandimprovephysicalperformance.
Astheactiveingredientofsibutraminemedicatioins,SibutraminehydrochlorideisavailableinAea.ltdsupplierinraw
powderform.Therawpowderformsibutraminehydrochloride,makesiteasytoincorporateintovariousdelivery

16. www.aea.ltd
APICMO&CDMOManufacturer
Email:[email protected]
methods,includingcapsules,tablets,weightlosscoffees,andchocolates.Thisversatilityallowssupplementscompanyto
createavarietyofproductstosuitconsumerpreferences.Ifsupplementscompanywanttobuyhighqualitysibutramine
hydrochloridepowdertomakesibutraminecoffeesorchocolatesetc,youcanbuyitfromAea.ltdmanufacturer.Buy
Sibutraminehydrochloridepowderinbulkwillgetfactoryprice.

17. www.aea.ltd
APICMO&CDMOManufacturer
Email:[email protected]
9.Whysibutramineispopularforweightloss
Sibutraminegainedpopularityforweightlossduetoitssignificantefficacyinpromotingbothinitialandsustainedweight
reduction.Itworkedbysuppressingappetitethroughtheinhibitionofneurotransmitterreuptake,makingiteasierfor
patientstoadheretoacalorie-restricteddiet.Beyondhelpingwithinitialweightloss,sibutraminealsoprovedeffectivein
maintainingweightlossovertime,addressingamajorchallengeinobesitymanagement.Patientsfrequentlyreported
positiveoutcomes,includingimprovedmetabolichealthandqualityoflife,whichledtohighsatisfactionratesand
positiveword-of-mouth.Themedication'sconvenience,withaonce-dailyoraldosage,enhancedadherence,andits
endorsementbyhealthcareprovidersaddedcredibility.Sibutraminewasoftenpartofacomprehensiveweight
managementplanthatincludeddietarychangesandincreasedphysicalactivity,furtherboostingitseffectiveness.These
factorscombinedtomakesibutramineapopularchoiceforweightlossuntilsafetyconcernsledtoitsmarketwithdrawal.

18. www.aea.ltd
APICMO&CDMOManufacturer
Email:[email protected]
10.Sibutraminehalf-life
Thehalf-lifeofsibutramineitselfisrelativelyshort,only1.1hours,butitsactivemetabolitesdesmethylsibutramine(M1)
anddidesmethylsibutramine(M2)arelonger-lasting,Approximately14hours-16hours.Theextendedhalf-livesofthe
activemetabolitesM1andM2allowforonce-dailydosingofsibutramine,astheysustainitspharmacologicaleffectsover
a24-hourperiod.Thisiswhythemedicationwastypicallyprescribedtobetakenoncedaily,usuallyinthemorning.
11.Sibutraminedosage
SibutraminewasvoluntarilywithdrawnfromtheUSmarketbythemanufacturerinOctober,2010duetoclinicaltrialdata
indicatinganincreasedriskofheartattackandstroke.Thefollowingdosageinformationappliestowhenthedrugwas
availableintheUS.Aea.ltdasSibutraminehydrochloridepowdersupplier,thesibutraminedosageherearefor
informationonly.

19. www.aea.ltd
APICMO&CDMOManufacturer
Email:[email protected]
Sibutraminecomesasacapsuleortablettobetakenbymouth,sibutraminehydrochloridepowderistheactiveingredient
ofthecapsuleortablet.Sibutraminehydrochloridepowderwastypicallyformulatedintooralcapsulesinvarying
strengths,usuallyrangingfrom5mgto15mg.
Itcanbetakeneitherwithorwithoutfood,generallyinthemorningtohelpmanageappetitethroughouttheday.
Sibutramineshouldnotbeusedformorethantwoyears.
Theusualstartingdoseforsibutraminewas10mgtakenoncedaily.Itcouldbetakenwithorwithoutfood,generally
inthemorningtohelpmanageappetitethroughouttheday.
Ifweightlosswasnotadequate,thedosecouldbeincreasedto15mgoncedailyafter4weeksoftreatment.
Insomecases,ifthepatientexperiencedsideeffectsorotherissues,thedosecouldbereducedto5mgoncedaily.
Thehighestdoserecommendedwas15mgoncedaily.Exceedingthisdosewasnotadvisedduetoincreasedriskof
sideeffects.

20. www.aea.ltd
APICMO&CDMOManufacturer
Email:[email protected]
12.WhatisSibutraminehydrochlorideSideEffects
Whilesibutraminehydrochloridewaseffectiveinpromotingweightloss,itwasalsoassociatedwitharangeofsideeffects,
someofwhichwereseriousandultimatelyledtoitsmarketwithdrawalinmanyregions.
CommonSideEffects:
DryMouth:Afeelingofdrynessinthemouthisquitecommon.
Constipation:Difficultorinfrequentbowelmovements.
Headache:Regularheadachesormigraines.
Insomnia:Difficultyfallingorstayingasleep.
Dizziness:Asensationofspinningorlightheadedness.
Flushing:Reddeningoftheskin,typicallyoverthecheeksorneck.

21. www.aea.ltd
APICMO&CDMOManufacturer
Email:[email protected]
Thesecommonsideeffectsweregenerallymildtomoderateandtendedtodiminishovertimeasthebodyadjustedtothe
medication.
SeriousSideEffects:
IncreasedBloodPressure:Sibutraminecancauseasignificantriseinbloodpressure.
IncreasedHeartRate:Usersmayexperiencetachycardia(rapidheartbeat).
HeartPalpitations:Irregularorforcefulheartbeats.
ChestPain:Discomfortorpaininthechestarea,potentiallyindicatingheartissues.
ShortnessofBreath:Difficultybreathingorfeelingoutofbreath.
Swelling:Edema,particularlyinthelegsandankles.
Mental/MoodChanges:Anxiety,depression,ormoodswings.

22. www.aea.ltd
APICMO&CDMOManufacturer
Email:[email protected]
Seizures:Convulsionsorfits,althoughrare.
SevereAllergicReactions:Rash,itching/swelling(especiallyoftheface/tongue/throat),severedizziness,trouble
breathing.
Long-termRisks:
CardiovascularEvents:Increasedriskofheartattackorstroke.
SerotoninSyndrome:Apotentiallylife-threateningconditioncausedbyexcessiveserotonin,characterizedbyconfusion,
rapidheartrate,andhighbloodpressure.

23. www.aea.ltd
APICMO&CDMOManufacturer
Email:[email protected]

24. www.aea.ltd
APICMO&CDMOManufacturer
Email:[email protected]
13.Sibutramineandcardiovascularrisks
Moreconcerningwerethecardiovascularsideeffectslinkedtosibutramineuse.Clinicaltrialsandpost-marketing
surveillanceidentifiedanincreasedriskofelevatedbloodpressureandheartrate,whichposedsignificantriskstopatients
withahistoryofcardiovasculardisease.ThisriskprofilebecameparticularlyevidentintheSCOUT(Sibutramine
CardiovascularOutcomesTrial)study,whichshowedanincreasedincidenceofheartattackandstrokeamongpatients
withpreexistingcardiovascularconditions.RegulatoryagenciesliketheFDAandtheEuropeanMedicinesAgencyactedon
thesefindings,requestingthedrug'sremovaltoprotectpublichealth.Asaresult,individualsseekingweightmanagement
solutionsareadvisedtoconsulthealthcareprovidersforsaferalternatives,focusingonlifestylechanges,behavioral
therapy,orothermedicationswithabettersafetyprofile.

25. www.aea.ltd
APICMO&CDMOManufacturer
Email:[email protected]
14.SibutramineSCOUTStudyOverview
SCOUTwasarandomised,double-blind,placebocontrolledstudyinapproximately10000obeseandoverweightpatients
withcardiovasculardiseaseand/ortype2diabetestreatedovera6-yearperiod.Theresultsshowedthatthesehigh-risk
patientstreatedwithsibutraminehada16%increasedriskofcardiovascularadverseeventssuchasmyocardialinfarction
andstrokecomparedwithplacebo-treatedpatients(hazardratio1·161[95%CI1·029–1·311];p=0·016).Furthermore,the
meanweightlossachievedwithsibutramineinallclinicaltrialsismodest,decreasingbodyweightbyapproximately2–4kg
morethanplacebowhichmaynotbesustainedaftercessationoftreatment.
15.WhatisthemostimportantinformationIshouldknowaboutsibutramine?
SibutraminewaswithdrawnfromtheU.S.marketinOctober2010.
DonotusesibutramineifyouhavetakenanMAOinhibitorsuchasfurazolidone(Furoxone),isocarboxazid(Marplan),
phenelzine(Nardil),rasagiline(Azilect),selegiline(Eldepryl,Emsam),ortranylcypromine(Parnate)inthelast14days.

26. www.aea.ltd
APICMO&CDMOManufacturer
Email:[email protected]
Serious,lifethreateningsideeffectscanoccurifyouusesibutraminebeforetheMAOinhibitorhasclearedfromyour
body.
Youshouldnottakesibutramineifyouareallergictoit,orifyouhavesevereoruncontrolledhighbloodpressure,an
eatingdisorder(anorexiaorbulimia),ifyouaretakingstimulantdietpills,orifyouhaveahistoryofcoronaryartery
disease,stroke,orheartdisease.
Beforetakingsibutramine,tellyourdoctorifyouhaveglaucoma,highbloodpressure,liverorkidneydisease,depression,
underactivethyroid,seizures,ableedingdisorder,ahistoryofgallstones,orifyouareolderthan65oryoungerthan16.
Tellyourdoctoraboutallprescriptionandover-the-countermedicationsyouuse,especiallyantidepressants,coldor
allergymedication,narcoticpainmedicine,ormigraineheadachemedicines.
Tellyourdoctorifyoudonotloseatleast4poundsaftertakingthemedicationfor4weeksalongwithalowcaloriediet.

27. www.aea.ltd
APICMO&CDMOManufacturer
Email:[email protected]
16.Sibutramineinteractions
Sibutramineinteractionwithothermedicationswasanothercriticalconsiderationforitssafeuse.Duetoitsmechanismas
aserotonin-norepinephrinereuptakeinhibitor,sibutraminehadthepotentialtointeractwithotherdrugsthatinfluence
serotoninlevels,leadingtoariskofserotoninsyndrome—apotentiallylife-threateningconditioncharacterizedby
symptomssuchasagitation,hallucinations,rapidheartrate,andincreasedbodytemperature.
Concomitantuseofsibutraminewithotherserotonergicagents,suchasselectiveserotoninreuptakeinhibitors(SSRIs),
monoamineoxidaseinhibitors(MAOIs),ortriptans(usedformigrainetreatment),wasgenerallycontraindicateddueto
thisrisk.PatientswereadvisedtodiscontinueanyMAOIsatleasttwoweekspriortostartingsibutraminetoavoid
dangerousinteractions.

28. www.aea.ltd
APICMO&CDMOManufacturer
Email:[email protected]
Additionally,sibutramine'seffectsonbloodpressureandheartratenecessitatedcautionwhenusedwithother
medicationsthatinfluencedcardiovascularfunction,suchasantihypertensives,decongestants(likepseudoephedrine),
andcertainantipsychotics.
Giventhedrug'smetabolismbythecytochromeP4503A4(CYP3A4)enzyme,interactionswithinhibitorsorinducersof
thisenzymecouldaltersibutramine'splasmalevels,affectingitsefficacyandsafety.Forexample,concomitantusewith
ketoconazole(apotentCYP3A4inhibitor)couldincreasesibutraminelevels,heighteningtheriskofadverseeffects,while
usewithCYP3A4inducers(likerifampicin)couldreduceitseffectiveness.
Inconclusion,sibutramineservedasasignificantpharmacologicaltoolinobesitymanagementbutalsohighlightedthe
importanceofbalancingefficacywithsafety.Itscomplexmechanismofaction,alongsidethepotentialforseriousside
effectsanddruginteractions,underscoresthenecessityforongoingresearchinthedevelopmentofsaferweightloss
therapeutics.

29. www.aea.ltd
APICMO&CDMOManufacturer
Email:[email protected]
17.IssibutraminesafetotakeifI'mpregnantorbreastfeeding?
Noadequatestudieswithsibutraminehavebeendoneinpregnantwomen.Theuseofsibutramineduringpregnancy,
therefore,isnotrecommended.Womenwhocouldbecomepregnantshoulduseadequatecontraceptionwhiletaking
sibutramine.Itisunknownwhethersibutramineoritsactiveproductsaccumulateinbreastmilk.Sibutramine,therefore,
isnotrecommendedfornursingmothers.

30. www.aea.ltd
APICMO&CDMOManufacturer
Email:[email protected]
18.SibutramineResult
Sibutraminefightobesityeffectively.Sibutramineimprovessatiety,asaresult,youmightalwaysfeelfulleronceyoutake
itthusdecreasingyourtemptationsofsnackinganythingelseapartfromyourregularmeals.Ifyou’vebeenstrugglingto
controltheportionsofyourfood,thismedicationwillbeofgreathelpbecauseitwillreducetheurgetoeatmore.Italso
increasesenergyexpenditureinthebodybyimprovingthermogenesis.Thermogenesisistheprocesswherethereisthe
productionofheatinthebodythroughtheburningofcalories.OnceonestartstakingtheSibutraminemedication,thereis
aremarkablereductionintheamountoffatsinthebody.A5-10%reductionisnoticedinthebaselineweightofpatients
whotakeit.Thereisalsoareductioninthewaistcircumference,reducedvisceralfattissueandanimprovedlipidprofile.
Boththediastolicandsystolicbloodpressurehavebeenreportedtodecreasesignificantly

31. www.aea.ltd
APICMO&CDMOManufacturer
Email:[email protected]
19.Sibutraminereview
Sibutraminewasonceaveryeffectiveweightlossdrug.Thefollowingreviewshighlighttheexperiencesofindividualswho
foundsibutraminetransformativeintheirweightlossjourneys,expressingfrustrationoveritswithdrawalandadvocating
foritsreconsiderationunderstrictmedicalsupervision.
"Iamreallydisappointedthatthismedicationwastakenoffthemarket.Iusedtoconstantlythinkaboutfoodandate
largeportionsallthetime.WhenItookMeridiafortwomonthsbeforeitwasdiscontinued,Ilost20poundswithout
exercising.Myobsessionwithfooddecreasedsignificantly,andIstartedcravinghealthieroptionsandeatingsmaller
portions,feelingsatisfiedwithless.Theweightlosshappenedeffortlessly,andIfoundmyselfwithmuchmorefreetime
notspentthinkingaboutfood.It'sfrustratingthatitwasremovedduetocardiacconcerns.Afterall,evenheart
medicationscanhavecardiacsideeffects,yettheyremainavailable."

32. www.aea.ltd
APICMO&CDMOManufacturer
Email:[email protected]
"Ireallydon'tunderstandwhyMeridiawasdiscontinued.Itworkedexceptionallywellformein2008.Toensureitwas
safe,Ididheartstresstestingbeforestartingandvisitedmydoctormonthlytomonitormyprogressandoverallwell-being.
Meridiaeffectivelycurbedmyconstanthunger,leadingtoaweightlossof35-40poundsoverfivemonths.Ifeltfantastic
andmanagedtokeeptheweightoffforthreeyears,withmyappetiteremainingreducedthroughoutthatperiod.Unlike
someothermedications,itdidn'tmakemefeeljittery;instead,Ihadincreasedenergywithoutanynervousness.Thisextra
energyboostedmyworkoutsandoverallpositivity.Ibelievethismedicationshouldbereconsideredforuse,asitproved
highlyeffectivewhencarefullyprescribedandmonitored.TheFDAshouldre-evaluateitwithnewstudies,ascurrent
alternativesdon'tmeasureup."
"Ilovedthisdietpill!Ithadnosideeffectsanditworkedperfectlyforme.Ilost20poundsinjustonemonth.I'mvery
upsetthatit'soffthemarket.Ionlyuseditthatonetime,butifIeverneededtoloseweightagain,Iwoulddefinitelywant
touseitagain!"

33. www.aea.ltd
APICMO&CDMOManufacturer
Email:[email protected]
"Iusedthisbackin2009andlostover4stone.Itwasamazing.Myappetitewasalmostnonexistent,andIfeltfullafter
justafewmouthfuls.ThesideeffectsIexperiencedincludeddrymouth,someagitation,aninabilitytostaystillforlong,
andinsomnia.However,bytakingitveryearlyinthemorningandavoidingcaffeine,Iwasabletomanagetheinsomnia.I
hadtostoptakingitwhenitwaspulledfromthemarket,andunfortunately,I'veput2stonebackonsincethen.Aftera
longsearch,I'vemanagedtogetsomemoreandhopetoseethesameresults."
"IamsothankfulmydoctorprescribedmeMeridia.Aftergivingbirthat37yearsold,Igained65extrapoundsthat
wouldn'tcomeoffdespitedietandexercise.I'mhappytosayI'velost60poundswithMeridia.Regardingthesafety
debate,itreallydependsonyourdoctor.Ifyouhaveheartconditions,youshouldn'ttakethisproduct,andyourdoctor
shoulddetermineifit'ssafeforyou.I'mnolongeronMeridiaandhaven'tgainedanyweightback.Thankyou,thankyou,
thankyou.Ifeelsomuchhealthiernow."
TogetmaximumbenefitsfromSibutramine,itisalwaysimportanttobuypuresibutraminehydrochloridepowderfrom
reputablesupplier.

34. www.aea.ltd
APICMO&CDMOManufacturer
Email:[email protected]
20.HowshouldIkeepsibutraminestored?
SibutramineCapsulesshouldbestoredat25°C(77°F).Briefperiodsathigherorlowertemperatures,i.e.,15-30°C(59-86°F)
arepermitted.Themedicationshouldbestoredinatight,light-resistantcontainer.Thecapsulesshouldbeprotectedfrom
heatandmoisture.
Whenitcomestosibutraminehydrchloridepowder,youshouldkeepitatacontrolledroomtemperatureofaround25°C
(77°F),withshort-termfluctuationsbetween15-30°C(59-86°F)beingacceptable.Thepowdershouldbekeptinacool,dry
place,awayfromsourcesofheatandmoisture,topreventclumpingordegradation.Followingthesestorageguidelines
providedbythesibutraminehydrochloridemanufacturer,guildelineswillbevaryfromsuppliers,ensuresthatthe
sibutraminehydrochloridepowderremainsstableandeffectiveforitsintendeduse.

35. www.aea.ltd
APICMO&CDMOManufacturer
Email:[email protected]

36. www.aea.ltd
APICMO&CDMOManufacturer
Email:[email protected]
21.Sibutraminecost
Thewholesalecostofsibutramineperdayvariesbasedonthedosageofthecapsules.Forthe5mgand10mgcapsules,
thecostisapproximately$2.78perday,whilethe15mgcapsulecostsabout$3.60perday.Thesepricesprovideageneral
ideaofthemedication'scostwhenitwasavailableonthemarket.
Sibutraminehclpowderastheactiveingredientofsibutramineweightlossmedications,itspriceismuchcheaperthanthe
commercialdrug.Manufacturerorresearcherwhowanttobuysibutraminehclrawpowdertodotheresearchor
compoundtheirweightlosssupplements,buysibutraminehclbulkwillgetfactorypricefromAea.ltd.
22.Sibutraminehydrochloridepowdermanufacturer
Ifyouneedtolosesomepounds,thentheSibutraminegotyoucovered.Notonlydoesithelpyouloseweightbutitisa
long-termmethodbecauseitpreventstheregainingofthelostfat.

37. www.aea.ltd
APICMO&CDMOManufacturer
Email:[email protected]
However,Sibutraminewasaprescriptionmedicationusedasanappetitesuppressanttoaidweightlossinindividuals
strugglingwithobesity.Withoutprescription,youcan'tbuyitover-the-counter.Soitwashardforsomeindividuals
seekingloseweighttobuyitonpharmacy.Sotheychoosetopurchasesibutraminehydrochloridepowderonline.
Sibutraminehclpowderonlineistherawpowder,youcanbuyitfreelywithoutdoctor'sprescription,butmakesureyou
buyitfromthetrustedmanufacturer.
23.Reference
[1]SeravalleG,GrassiG."Obesityandhypertension."PharmacolRes.2017Aug;122:1-7.doi:10.1016/j.phrs.2017.05.013.Epub2017May
19.PMID:28532816
[2]PichéME,TchernofA,DesprésJP."ObesityPhenotypes,Diabetes,andCardiovascularDiseases."CircRes.2020May22;126(11):1477-1500.
doi:10.1161/CIRCRESAHA.120.316101.Epub2020May21.PMID:32437302
[3]PostonWS,ForeytJP."Sibutramineandthemanagementofobesity."ExpertOpinPharmacother.2004Mar;5(3):633-42.doi:
10.1517/14656566.5.3.633.PMID:15013931
[4]LeanME."Sibutramine--areviewofclinicalefficacy."IntJObesRelatMetabDisord.1997Mar;21Suppl1:S30-6;discussion37-9.PMID:
9130039

38. www.aea.ltd
APICMO&CDMOManufacturer
Email:[email protected]
[5]StockMJ."Sibutramine:areviewofthepharmacologyofanovelanti-obesityagent."IntJObesRelatMetabDisord.1997Mar;21Suppl
1:S25-9.PMID:9130038
[6]LuqueCA,ReyJA."Sibutramine:aserotonin-norepinephrinereuptake-inhibitorforthetreatmentofobesity."AnnPharmacother.1999
Sep;33(9):968-78.doi:10.1345/aph.18319.PMID:10492502
[7]FinerN."Sibutramine:itsmodeofactionandefficacy."IntJObesRelatMetabDisord.2002Dec;26Suppl4:S29-33.doi:
10.1038/sj.ijo.0802216.PMID:12457297
[8]SharmaB,HendersonDC."Sibutramine:currentstatusasananti-obesitydruganditsfutureperspectives."ExpertOpinPharmacother.2008
Aug;9(12):2161-73.doi:10.1517/14656566.9.12.2161.PMID:18671470
[9]RyanDH."Clinicaluseofsibutramine."DrugsToday(Barc).2004Jan;40(1):41-54.doi:10.1358/dot.2004.40.1.799437.PMID:14988769
[10]McNeelyW,GoaKL."Sibutramine.Areviewofitscontributiontothemanagementofobesity."Drugs.1998Dec;56(6):1093-124.doi:
10.2165/00003495-199856060-00019.PMID:9878996
[11]TziomalosK,KrassasGE,TzotzasT."Theuseofsibutramineinthemanagementofobesityandrelateddisorders:anupdate."VascHealth
RiskManag.2009;5(1):441-52.doi:10.2147/vhrm.s4027.PMID:19475780
[12]FilippatosTD,KiortsisDN,LiberopoulosEN,MikhailidisDP,ElisafMS."Areviewofthemetaboliceffectsofsibutramine."CurrMedResOpin.
2005Mar;21(3):457-68.doi:10.1185/030079905X38132.PMID:15811215
[13]ShakeelKhanMK."Sibutramineanditscardiovasculareffects:Adeadlycombination."JPakMedAssoc.2021Dec;71(12):2850.doi:
10.47391/JPMA.4004.PMID:35150561
[14]"Sibutramine(Meridia)withdrawn."MedLettDrugsTher.2010Nov1;52(1350):88.PMID:21045763

39. www.aea.ltd
APICMO&CDMOManufacturer
Email:[email protected]
[15]LeanME."Howdoessibutraminework?"IntJObesRelatMetabDisord.2001Dec;25Suppl4:S8-11.doi:10.1038/sj.ijo.0801931.PMID:
11916106
[16]WilliamsG."WithdrawalofsibutramineinEurope."BMJ.2010Feb9;340:c824.doi:10.1136/bmj.c824.PMID:20144986
[17]WanR,SongH,QuG,RenL,ZhouX,TianQ,WangY,LiuL."Cardiogenicshockina28-year-oldwomanassociatedwithsibutramine
use."IntJLegalMed.2024May;138(3):833-838.doi:10.1007/s00414-023-03147-2.Epub2024Jan10.PMID:38197924
[18]PrzegalińskiE,WitekK,WydraK,KotlińskaJH,FilipM."5-HT2CReceptorStimulationinObesityTreatment:OrthostericAgonistsvs.
AllostericModulators."Nutrients.2023Mar17;15(6):1449.doi:10.3390/nu15061449.PMID:36986191